PKX arrives at its July 2 earnings print having shed a third of its value in a single month — a selloff severe enough to reframe what the results actually need to say.
The price collapse is the dominant context here. PKX closed at $49.96 on June 26, down 34% over the past 30 days and another 18% on the week alone. That kind of move compresses the debate considerably: bulls are no longer arguing for a re-rating, they are arguing the selloff has been overdone. Options positioning reflects the shift in mood. The put/call ratio has climbed to 0.47, roughly 1.5 standard deviations above its 20-day average of 0.37 — still well below panic levels, but a meaningful step up from the call-heavy positioning that dominated through May, when the PCR ran as low as 0.13. Investors who were net optimistic a month ago are now paying measurably more for downside protection.
The borrow market tells a more relaxed story than the price action might suggest. Availability has loosened dramatically — from a near-squeeze at roughly 11% in late May, it has rebounded to 236%, meaning there are more than two shares available to borrow for every one already lent out. Short interest itself has fallen about 22% over the past month to roughly 744,000 shares. Cost to borrow is low at 0.71%, though it has ticked up 33% on the week, hinting at modest fresh demand for borrows even as the overall lending pool loosens. The short score of 61.8 ranks in the 85th percentile of the universe for short interest positioning — elevated, but not extreme given how far availability has recovered. The borrow market is not signaling a squeeze setup; if anything, the easing of conditions since late May suggests the most intense short pressure has already passed.
The fundamental debate heading into the print is between two credible reads on the same stock. The bear case centres on challenged earnings power: a five-year EBIT CAGR of minus 18%, negative free cash flow, and a steel sector navigating soft Chinese demand and compressed margins. The bull case leans heavily on valuation — price-to-book near 0.46 is deeply discounted, analysts see meaningful upside to target, and the EPS surprise factor score ranks in the 80th percentile. UBS upgraded to Buy in late April, a relevant recent signal from a bellwether firm. The consensus price target of $111.42 is stale (the consensus data is from 2023) and should not be read as current Street conviction, but the direction of recent analyst activity has leaned constructive even as the stock has collapsed. The most recent earnings event — April 30 — produced a 3% one-day gain and a 16% five-day rally, a reminder that negative sentiment can unwind quickly after a clean print.
The July 2 report is therefore a test of whether the severity of the selloff reflects a genuine deterioration in the underlying steel business, or whether the market has overshot what the fundamentals warrant.
See the live data behind this article on ORTEX.
Open PKX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
